01 Beacon Therapeutics公布了在研基因疗法laru-zova在治疗X连锁视网膜色素变性 (XLRP)患者的2期临床试验DAWN中获得的3个月中期安全性和疗效数据。 Beacon ...

12月8日，随着最后一场活动的精彩落幕，为期四天的2024年三亚时尚生活展圆满收官。此次展会以“BEST ...

Renowned Taiwan writer Chiung Yao passed away at her home in New Taipei City on Wednesday. She was 86. Her son said that when ...